Evidence map›Paper›PMID 42638635›Full record

ArticleFrontiers in tuberculosis2025

Tissue-specific T cell profiles in

Gift Ahimbisibwe, Marjorie Nakibuule, Marvin Martin Ssejjoba, Claire Precious Bisoboka, Feddy Gift Akello, Marvin Joven Turyasingura, Rose Mulwana, Josephine Nabulime, Febronius Babirye, Musana Abdusalaamu Kizito and 8 more

Abstract read
In one paragraph

Article in Frontiers in tuberculosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Gift AhimbisibweMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Marjorie NakibuuleMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Marvin Martin SsejjobaMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Claire Precious BisobokaMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Feddy Gift AkelloMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Marvin Joven TuryasinguraMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Rose MulwanaMulago National Referral Hospital, Kampala, Uganda.
Josephine NabulimeMulago National Referral Hospital, Kampala, Uganda.
Febronius BabiryeMulago National Referral Hospital, Kampala, Uganda.
Musana Abdusalaamu KizitoMulago National Referral Hospital, Kampala, Uganda.
Hervé Monka LekuyaMulago National Referral Hospital, Kampala, Uganda.
Akello Suzan AdakunMulago National Referral Hospital, Kampala, Uganda.
Daisy NalumansiMulago National Referral Hospital, Kampala, Uganda.
Stella MuryasinguraMulago National Referral Hospital, Kampala, Uganda.
Robert LukandeDepartment of Pathology, Makerere University, Kampala, Uganda.
Joseph Baruch BalukuMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Irene Andia BiraroDepartment of Internal Medicine, Makerere University, Kampala, Uganda.
Stephen CoseMRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.

Funding

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - SARS-CoV-2 RELATED RESEARCH75N93019C00070 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI URDAHL, KEVIN · 2019 to 2025
$86.6M
NIH HHS 75N93019C00070
6 · The paper itself

Abstract

Introduction: Interferon-gamma release assays (IGRAs), such as the T-SPOT. Methods: Post-mortem tissues, including lung, lymph nodes, spleen, and bronchoalveolar lavage, were collected from apparently healthy, HIV-negative road traffic accident victims. M.tb infection was ruled out using liquid MGIT culture, while M.tb exposure history was assessed with the TSPOT. Results: Of the 52 individuals recruited, 48% were IGRA-positive (TSPOT+). Using a 29-color flow cytometry panel, we analyzed T and B cell populations across various tissues. We observed similar overall frequencies of CD3, CD4, CD8, and CD19 cells, as well as memory T and B cell subsets defined by CCR7/CD45RA and IgD/CD27 between TSPOT+ and TSPOT individuals. Notably, in the lungs, TSPOT+ individuals exhibited a higher frequency of CD4+ tissue-resident memory (TRM) T cells, along with increased expression of KLRG1, a marker of terminal differentiation, on mature CD4+CD27 T cells. This phenotype was specific to CD4 T cells in the lungs, highlighting the known role of CD4 T cells in TB immunity and their localization to the primary site of infection. Discussion: Our findings suggest that IGRA positivity, while indicating immune memory, may also be associated with highly differentiated CD4 T cells in tissue-specific compartments, particularly in the lungs. These localized immune changes raise important questions about the long-term effects of chronic immune engagement following repeated M.tb exposure in endemic settings. Further research is needed to assess the clinical implications of these findings, including their impact on susceptibility to future infections or disease progression.

Indexed as

IGRAMycobacterium tuberculosisT cellstissuesTRMs

Identifiers

PMID42638635
PMCPMC13494974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.